BGMS PE Ratio & Valuation,Is BGMS Overvalued — Intellectia
BGMS Relative Valuation
BGMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BGMS is overvalued; if below, it's undervalued.
Historical Valuation
Bio Green Med Solution Inc(BGMS) is now in theFairzone, suggesting that its currentforward PSratio of0.00is consideredFairlycompared with the five-year average of-0.02.The fair price ofBio Green Med Solution Inc(BGMS)is betweenNaNtoNaNaccording to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：1.30
Fair
-0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Bio Green Med Solution Inc. (BGMS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-0.34
EV/EBIT
Bio Green Med Solution Inc. (BGMS) has a current EV/EBIT of -0.34. The 5-year average EV/EBIT is -0.78. The thresholds are as follows: Strongly Undervalued below -1.76, Undervalued between -1.76 and -1.27, Fairly Valued between -0.29 and -1.27, Overvalued between -0.29 and 0.20, and Strongly Overvalued above 0.20. The current Forward EV/EBIT of -0.34 falls within the Historic Trend Line -Fairly Valued range.
70.56
PS
Bio Green Med Solution Inc. (BGMS) has a current PS of 70.56. The 5-year average PS is 115.05. The thresholds are as follows: Strongly Undervalued below 20.73, Undervalued between 20.73 and 67.89, Fairly Valued between 162.22 and 67.89, Overvalued between 162.22 and 209.38, and Strongly Overvalued above 209.38. The current Forward PS of 70.56 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Bio Green Med Solution Inc. (BGMS) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
-0.08
P/FCF
Bio Green Med Solution Inc. (BGMS) has a current P/FCF of -0.08. The 5-year average P/FCF is -0.14. The thresholds are as follows: Strongly Undervalued below -0.25, Undervalued between -0.25 and -0.19, Fairly Valued between -0.08 and -0.19, Overvalued between -0.08 and -0.02, and Strongly Overvalued above -0.02. The current Forward P/FCF of -0.08 falls within the Historic Trend Line -Fairly Valued range.
Bio Green Med Solution Inc (BGMS) has a current Price-to-Book (P/B) ratio of 0.68. Compared to its 3-year average P/B ratio of 1.82 , the current P/B ratio is approximately -62.89% higher. Relative to its 5-year average P/B ratio of 1.82, the current P/B ratio is about -62.89% higher. Bio Green Med Solution Inc (BGMS) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -67.52%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -67.52% , the current FCF yield is about -100.00% lower.
0.68
P/B
Median3y
1.82
Median5y
1.82
-86.35
FCF Yield
Median3y
-67.52
Median5y
-67.52
Competitors Valuation Multiple
The average P/S ratio for BGMS's competitors is 0.00, providing a benchmark for relative valuation. Bio Green Med Solution Inc Corp (BGMS) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 710.00%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BGMS decreased by 72.67% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 10.00K to 81.00K.
The secondary factor is the Margin Expansion, contributed -93.77%to the performance.
Overall, the performance of BGMS in the past 1 year is driven by Revenue Growth. Which is more sustainable.
Is Bio Green Med Solution Inc (BGMS) currently overvalued or undervalued?
Bio Green Med Solution Inc(BGMS)is now in theFairzone, suggesting that its currentforward PSratio of 0.00is consideredFairlycompared with the five-year average of-0.02.The fair price of Bio Green Med Solution Inc(BGMS)is betweenNaNtoNaNaccording to relative valuation methord.
What is Bio Green Med Solution Inc (BGMS) fair value?
BGMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Bio Green Med Solution Inc (BGMS) is between NaNtoNaN according to relative valuation methord.
How does BGMS's valuation metrics compare to the industry average?
The average P/S ratio for BGMS's competitors is 0.00, providing a benchmark for relative valuation. Bio Green Med Solution Inc Corp (BGMS) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 710.00%, this premium appears sustainable.
What is the current P/B ratio for Bio Green Med Solution Inc (BGMS) as of Dec 16 2025?
As of Dec 16 2025, Bio Green Med Solution Inc (BGMS) has a P/B ratio of 0.68. This indicates that the market values BGMS at 0.68 times its book value.
What is the current FCF Yield for Bio Green Med Solution Inc (BGMS) as of Dec 16 2025?
As of Dec 16 2025, Bio Green Med Solution Inc (BGMS) has a FCF Yield of 0.00%. This means that for every dollar of Bio Green Med Solution Inc’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for Bio Green Med Solution Inc (BGMS) as of Dec 16 2025?
As of Dec 16 2025, Bio Green Med Solution Inc (BGMS) has a Forward P/E ratio of -0.00. This means the market is willing to pay $-0.00 for every dollar of Bio Green Med Solution Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Bio Green Med Solution Inc (BGMS) as of Dec 16 2025?
As of Dec 16 2025, Bio Green Med Solution Inc (BGMS) has a Forward P/S ratio of 0.00. This means the market is valuing BGMS at $0.00 for every dollar of expected revenue over the next 12 months.
